Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04242238
Title Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications

leiomyosarcoma

liposarcoma

myxofibrosarcoma

sarcoma

Therapies

Avelumab + Vimseltinib

Age Groups: senior | adult | child
Covered Countries USA


No variant requirements are available.